Disciplined Investments, LLC Amgen Inc Transaction History

Disciplined Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $214 - $253	-1 Reduced 1.06%	93 $20,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $1,580 - $1,926	-7 Reduced 6.93%	94 $22,000
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $1,571 - $1,772	-7 Reduced 6.48%	101 $23,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $2,768 - $3,080	12 Added 12.5%	108 $26,000
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $10,086 - $11,158	46 Added 92.0%	96 $23,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $10,613 - $12,435	50 New	50 $11,000
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $61,947 - $68,890	-264 Closed	0 $0
Q1 2020 May 19, 2020	SELL	$182.24 - $241.7 $1,822 - $2,417	-10 Reduced 3.65%	264 $54,000
Q4 2019 May 19, 2020	BUY	$189.21 - $243.2 $51,843 - $66,636	274 New	274 $66,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.